Riskpilot← Back to searchSign inGet full accessHKE Medical AB
ABActiveOrg 5590527320Lilla Nygatan 11Medical specialists activities · NACE 8622Est. 20161-4 employees
Revenue 2024
SEK 0
EBITDA margin
—
-53% vs 2023
Equity ratio
70.3%
Financial strength
Net profit 2024
SEK -262K
-56% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -279K | -53% |
| Net profit | SEK -262K | -56% |
| Total assets | SEK 1,3M | +2% |
| Equity | SEK 893K | -23% |
| Employees | — | — |
Legal name
HKE Medical AB
Org number
5590527320
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
25 februari 2016
Share capital
SEK 50 000
Employees
1-4
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva läkarpraktik samt därmed förenlig verksamhet.
Address
Lilla Nygatan 11
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 302 | 1 165 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 18 | 214 | 969 | −182 | −279 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 18 | 214 | 969 | −182 | −279 |
| Net financials | — | — | 1 | 14 | 17 |
| Profit before tax | 18 | 214 | 970 | −168 | −262 |
| Tax | −0 | −14 | −200 | −0 | −0 |
| Net profit | 18 | 200 | 770 | −168 | −262 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 391 | 860 | 1 402 | 1 242 | 1 270 |
| Equity | 353 | 553 | 1 323 | 1 155 | 893 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 38 | 306 | 79 | 87 | 377 |
| Total debt | 38 | 306 | 79 | 87 | 377 |
EBITDA margin
-27900000.0%
This company
15.8%
Market median
-176582378% vs market
20202024
Equity ratio
70.3%
This company
38.2%
Market median
+84% vs market
20202024
Return on equity
-29.3%
This company
18.4%
Market median
-259% vs market
20202024
Net profit margin
-26200000.0%
This company
8.1%
Market median
-323456890% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.42×
This company
0.62×
Market median
+32% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SE Authorized Recipient of Service | Authorized Recipient of Service | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of HKE Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sofie Elisabet Berggreen-Clausen | Authorized Recipient of Service | 0 companies |
| Micha Thuge Enevoldsen | Deputy Board Member | 0 companies |
| Henriette Köhler Enevoldsen | Board of Directors | 0 companies |